Bellicum Pharmaceuticals
Stock Forecast, Prediction & Price Target
Bellicum Pharmaceuticals Financial Estimates
Bellicum Pharmaceuticals Revenue Estimates
Bellicum Pharmaceuticals EBITDA Estimates
Bellicum Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2025 | |||
Revenue
% change YoY
| $500K N/A | $6.2M 1140% | $1.5M -75.80% | Avg: $6M Low: $6M High: $6M avg. 300% | |||
Net Income
% change YoY
| $-8.61M N/A | $-9.57M -11.12% | $-24.97M -160.73% | Avg: $-15.41M Low: $-15.41M High: $-15.41M avg. 38.27% | |||
EBITDA
% change YoY
| $2.39M N/A | $-24.34M -1118.36% | $-28.93M -18.83% | Avg: $-6M Low: $-6M High: $-6M avg. 79.26% | |||
EPS
% change YoY
| -$1.5 N/A | -$0.83 44.66% | -$0.81 2.40% | Avg: -$0.5 Low: -$0.5 High: -$0.5 avg. 38.27% | |||
Operating Expenses
% change YoY
| $54.58M N/A | $30.58M -43.96% | $28.48M -6.88% | Avg: $0 Low: $0 High: $0 avg. -100% | |||
FAQ
What is Bellicum Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 38.27% in 2025-2025.
We have gathered data from N/A analysts. Their low estimate is -15.41M, average is -15.41M and high is -15.41M.
What is Bellicum Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 300% in 2025-2025.
We have gathered data from N/A analysts. Their low revenue estimate is $6M, average is $6M and high is $6M.
What is Bellicum Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 38.27% in 2025-2025.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$0.5, average is -$0.5 and high is $-0.5.